Pulmonxcorp Stock Cash Per Share
| LUNG Stock | USD 9.82 0.44 4.69% |
PulmonxCorp fundamentals help investors to digest information that contributes to PulmonxCorp's financial success or failures. It also enables traders to predict the movement of PulmonxCorp Stock. The fundamental analysis module provides a way to measure PulmonxCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PulmonxCorp stock.
| Last Reported | Projected for Next Year | ||
| Cash Per Share | 3.09 | 2.58 |
PulmonxCorp | Cash Per Share |
PulmonxCorp Company Cash Per Share Analysis
PulmonxCorp's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current PulmonxCorp Cash Per Share | 4.35 X |
Most of PulmonxCorp's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PulmonxCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PulmonxCorp Cash Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for PulmonxCorp is extremely important. It helps to project a fair market value of PulmonxCorp Stock properly, considering its historical fundamentals such as Cash Per Share. Since PulmonxCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PulmonxCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PulmonxCorp's interrelated accounts and indicators.
Click cells to compare fundamentals
PulmonxCorp Cash Per Share Historical Pattern
Today, most investors in PulmonxCorp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PulmonxCorp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of PulmonxCorp cash per share as a starting point in their analysis.
PulmonxCorp Cash Per Share |
| Timeline |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
PulmonxCorp Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, PulmonxCorp has a Cash Per Share of 4.35 times. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 4.35) sector and 66.67% higher than that of the Health Care industry. The cash per share for all United States stocks is 13.17% higher than that of the company.
PulmonxCorp Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PulmonxCorp's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PulmonxCorp could also be used in its relative valuation, which is a method of valuing PulmonxCorp by comparing valuation metrics of similar companies.PulmonxCorp is currently under evaluation in cash per share category among related companies.
PulmonxCorp Current Valuation Drivers
We derive many important indicators used in calculating different scores of PulmonxCorp from analyzing PulmonxCorp's financial statements. These drivers represent accounts that assess PulmonxCorp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PulmonxCorp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4B | 2.5B | 1.2B | 312.7M | 484.2M | 460.0M | |
| Enterprise Value | 1.4B | 2.3B | 1.0B | 235.4M | 441.8M | 419.7M |
PulmonxCorp Fundamentals
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (0.77) % | ||||
| Current Valuation | 303.85 M | ||||
| Shares Outstanding | 38.81 M | ||||
| Shares Owned By Insiders | 4.67 % | ||||
| Shares Owned By Institutions | 92.80 % | ||||
| Number Of Shares Shorted | 1.73 M | ||||
| Price To Book | 2.59 X | ||||
| Price To Sales | 4.46 X | ||||
| Revenue | 68.67 M | ||||
| Gross Profit | 39.87 M | ||||
| EBITDA | (59.99 M) | ||||
| Net Income | (60.84 M) | ||||
| Cash And Equivalents | 162.09 M | ||||
| Cash Per Share | 4.35 X | ||||
| Total Debt | 41.42 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 9.43 X | ||||
| Book Value Per Share | 2.86 X | ||||
| Cash Flow From Operations | (37.61 M) | ||||
| Short Ratio | 2.57 X | ||||
| Earnings Per Share | (1.60) X | ||||
| Price To Earnings To Growth | (0.42) X | ||||
| Target Price | 15.4 | ||||
| Number Of Employees | 279 | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 381.13 M | ||||
| Total Asset | 178.95 M | ||||
| Retained Earnings | (411.16 M) | ||||
| Working Capital | 127.27 M | ||||
| Net Asset | 178.95 M |
About PulmonxCorp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PulmonxCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PulmonxCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PulmonxCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out PulmonxCorp Piotroski F Score and PulmonxCorp Altman Z Score analysis. For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for PulmonxCorp Stock analysis
When running PulmonxCorp's price analysis, check to measure PulmonxCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PulmonxCorp is operating at the current time. Most of PulmonxCorp's value examination focuses on studying past and present price action to predict the probability of PulmonxCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PulmonxCorp's price. Additionally, you may evaluate how the addition of PulmonxCorp to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is PulmonxCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PulmonxCorp. If investors know PulmonxCorp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PulmonxCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.60) | Revenue Per Share 1.909 | Quarterly Revenue Growth 0.297 | Return On Assets (0.21) | Return On Equity (0.46) |
The market value of PulmonxCorp is measured differently than its book value, which is the value of PulmonxCorp that is recorded on the company's balance sheet. Investors also form their own opinion of PulmonxCorp's value that differs from its market value or its book value, called intrinsic value, which is PulmonxCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PulmonxCorp's market value can be influenced by many factors that don't directly affect PulmonxCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PulmonxCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if PulmonxCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PulmonxCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.